Good afternoon, everyone, and welcome to IonQ's First Quarter 2026 Earnings Call. My name is Hanley Donofrio, and I am the Investor Relations Director here at IonQ. I'm pleased to be joined on today's ...

Pancreatic cancer remains one of the most difficult cancers to treat, with many patients facing a high risk of recurrence ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

Looking ahead to 2030, our model projects MRNA could trade at an average price of $46.81, with a potential range between $35.10 and $58.51. This represents a potential 13.9% decline from today's price ...

Once powerful AI models are released, it’s nearly impossible to keep them from being misused. Minimizing the risk means ...

A 2024 study by Qualtrics found that 23% of tax filers expected to go into debt to pay their tax bill, and another 23% said they’d need to take on new debt to resolve it. In fact, IRS data shows ...